Short Interest in Daxor Co. (NASDAQ:DXR) Declines By 13.6%

Daxor Co. (NASDAQ:DXR) saw a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 7,000 shares, a drop of 13.6% from the March 15th total of 8,100 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is presently 2.6 days.

Daxor Trading Up 0.6 %

Shares of Daxor stock traded up $0.05 on Tuesday, hitting $9.55. 577 shares of the company’s stock were exchanged, compared to its average volume of 3,441. The company has a 50-day simple moving average of $8.54 and a 200-day simple moving average of $8.57. Daxor has a 1 year low of $7.11 and a 1 year high of $13.13.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.